SCHEMBL4173523

SCHEMBL4173523

NC(CC(=O)O)Oc1ccc(Cl)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 12/20 0.50
PPARA Q07869 12/20 0.50
CYP2C9 P11712 3/20 0.50
KMT2A Q03164 3/20 0.50
MEN1 O00255 2/20 0.50
CYP2D6 P10635 2/20 0.50
CYP2C19 P33261 2/20 0.50
GABBR2 O75899 3/20 0.49
GABBR1 Q9UBS5 3/20 0.49
LMNA P02545 2/20 0.49
CYP3A4 P08684 1/20 0.49
ADORA3 P0DMS8 1/20 0.49
NFKB1 P19838 1/20 0.49
DRD3 P35462 1/20 0.49
BLM P54132 1/20 0.49
CYP1A2 P05177 1/20 0.49
THRB P10828 1/20 0.49
TSHR P16473 1/20 0.49
LTA4H P09960 1/20 0.44
SLC6A3 Q01959 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4170593 0.83 KMT2A (0.45) PPARGPPARAKMT2ACYP2C19GABBR2
SCHEMBL4180718 0.82 PPARG (0.47) PPARGPPARACYP2C9CYP2D6CYP2C19
SCHEMBL4183100 0.82 RXRA (0.39) KMT2ALTA4H
SCHEMBL4187784 0.82 L3MBTL1 (0.47) PPARGPPARAKMT2AMEN1LMNA
SCHEMBL4187187 0.82 LDHA (0.55) PPARGPPARAKMT2AMEN1LMNA
SCHEMBL9819006 0.79 KMT2A (0.52) PPARGPPARACYP2C9KMT2ACYP2C19
SCHEMBL4185056 0.77 TDP1 (0.55) PPARACYP2C9CYP2D6CYP2C19CYP3A4
SCHEMBL21991573 0.76 KMT2A (0.50) PPARGPPARACYP2C9KMT2ACYP2C19
SCHEMBL21991916 0.75 PPARG (0.50) PPARGPPARAKMT2ALTA4HSLC6A3
SCHEMBL4182560 0.74 TSHR (0.60) CYP2C9KMT2AMEN1LMNACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090227680-A1 Amino Acid Derivatives PFIZER, INC. (US) 2009-09-10 US claimed
EP-1951655-A2 AMINO ACID DERIVATIVES Pfizer Limited (GB) 2008-08-06 EP claimed
WO-2007057767-A2 AMINO ACID DERIVATIVES PFIZER LIMITED (GB) 2007-05-24 WO claimed
US-20090227680-A1 Amino Acid Derivatives PFIZER, INC. (US) 2009-09-10 US disclosed
EP-1951655-A2 AMINO ACID DERIVATIVES Pfizer Limited (GB) 2008-08-06 EP disclosed
WO-2007057767-A2 AMINO ACID DERIVATIVES PFIZER LIMITED (GB) 2007-05-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090227680-A1 Amino Acid Derivatives OPRL1, OPRK1, AVPR1A PPARG 2322/4885PPARA 1589/4885CYP2C9 2677/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.